missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies Nilotinib
Description
- Nilotinib is a second-generation inhibitor of the oncogenic tyrosine kinase BCR-ABL with IC50 values of 19, 140, and 9,200 nM for wild-type, E255K, and T315I mutant forms of BCR-ABL, respectively (Kitagawa et al.; Verstovsek et al.; O'Hare)
- It binds to the ATP-binding pocket of ABL, with higher affinity than imatinib (Manley et al. 2006; Verstovsek et al.) It also has activity below 1 μM against discoidin domain receptors (DDR) -1 and -2, platelet-derived growth factor receptors (PDGFR) –α and -β, stem cell factor receptor (KIT), and colony-stimulating factor 1 receptor (CSF-1R; Manley et al. 2010)
Specifications
Specifications
| CAS | 641571-10-0 |
| Synonym | AMN107; Tasigna |
| Quantity | 10 mg |
| Molecular Formula | C28H22F3N7O |
| Purity | ≥95% |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?